跳至主要内容
临床试验/NCT01860690
NCT01860690Unknown4 期

BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success

Meir Medical Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
100
试验地点
1
主要终点
To measure the change of levels of "BHCG" in patients receiving Methotrexate for treatment of ectopic pregnancy in days 4, 7, and 10 post treatment

研究概览

简要总结

The investigators want to compeer BHCG levels after Methotrexate ( MTX). treatment for Ectopic pregnancy in days 4 and 7 after MTX. to day 10 . The hypothesis is that "BHCG" level in day 10 is the best indicator for treatment success , superior to day 4 and 7 . According to the investigators impression BHCG level rises in days 4 and 7 due to destruction of the trophoblast tissue , and only day 10 is an indicator for treatment success

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • patients with ectopic pregnancy
  • hemodynamic stable
  • first ectopic

排除标准

  • hemodynamic non-stable
  • abnormal liver or kidney function
  • allergy reaction to MTX

研究组 & 干预措施

MTX , treatment outcome

Experimental

patient receiving MTX. in a dosage of 50 mg/m^2 , IM , in single dose

干预措施: Methotrexate (Drug)

结局指标

主要结局

To measure the change of levels of "BHCG" in patients receiving Methotrexate for treatment of ectopic pregnancy in days 4, 7, and 10 post treatment

时间窗: the change of levels in days 4, 7, and 10 post MTX injection

To compeer levels of BHCG in days 4 and 7 to day 10 after injection of MTX. for Ectopic pregnancy treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验